MedTrace Logo

Prophylactic Anti-epileptic Regimen in Traumatic Brain Injury

NCT07535736 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2026-04-17

No results posted yet for this study

Summary

To evaluate the effectiveness and safety of anti-epileptic drugs in the prevention of early and late post-traumatic seizures among patients with trauma brain injury

Conditions

  • Antiepileptic Efficacy and Safety
  • Brain Injuries

Interventions

DRUG

Anti-Epileptic

The anti-epileptic drugs will take three months

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mohammed A Taghyan, PhD · Assiut University

  • Ahmed A Ismail, PhD · Assiut University

  • Ismail A Taha, PhD · Assiut University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2027-05-30
Completion
2027-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07535736 on ClinicalTrials.gov